ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA.EGX)
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda stock price today, ATLAS forecast and fair value
Egyptian Exchange · Egypt
EGP 5.08▲ +5.83%
Prices as of Oct 27, 2026 · EGP
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between EGP 4.59 and EGP 5.55; in 9 out of 10, between EGP 3.88 and EGP 6.56. Estimated annual volatility is 57%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- EGP 7.39
- 52-week low
- EGP 3.06
- Operating margin
- 0.0%
- Net margin
- 0.0%
What this means
ATLAS does not publish a fair value for RMDA.EGX right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks RMDA.EGX has traded between EGP 3.06 and EGP 7.39. Today it is 31.3% below that high and 66% above its low.
Want to see everything about Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda?
Get started →Plans from €3.99 a month.
Frequently asked questions
What is the chance RMDA.EGX goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, RMDA.EGX ends the month between EGP 4.59 and EGP 5.55.
How volatile is RMDA.EGX?
ATLAS estimates annual volatility at 57%. In a typical month, half of the outcomes end between EGP 4.59 and EGP 5.55.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer